Sinae Kim

Sinae Kim

Auto-generated profile, based on publicly available information

Sinae Kim

Biostatistics Collaboration Team, Research Core Center, National Cancer Center, Goyang, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Gynecologic Oncology
Verified
Journal Article
Closed access
JKJisup Kim
Jisup Kim
SKSinae Kim
Sinae Kim
HLHye Sun Lee
Hye Sun Lee
WYWookyeom Yang
Wookyeom Yang
HCHanbyoul Cho
Hanbyoul Cho
Jae-Hoon KimJae-Hoon Kim
Jae-Hoon Kim

1 January 2019 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
DLDa Hyun Lee
Da Hyun Lee
CYChoon-Sik Yoon
Choon-Sik Yoon
BLBeom Jin Lim
Beom Jin Lim
HLHye Sun Lee
Hye Sun Lee
SKSinae Kim
Sinae Kim
SKSungjun Kim
Sungjun Kim
Lee DH, et al. Korean J Radiol. 2019 Oct;20(10):1409-1421. https://doi.org/10.3348/kjr.2019.0241

1 May 2023 in Radiology
Verified
Journal Article
Closed access
MKMi-ri Kwon
Mi-ri Kwon
JCJi Soo Choi
Ji Soo Choi
MLMi Yeon Lee
Mi Yeon Lee
SKSinae Kim
Sinae Kim
EKEun Sook Ko
Eun Sook Ko
BHBoo Kyung Han
Boo Kyung Han
Background Automated breast (AB) US effectively depicts mammographically occult breast cancers in Western women. However, few studies have focused on the outcome of supplemental AB US in Asian women who have denser breasts than Western women. Purpose To evaluate the performance of supplemental AB US on mammography-based breast cancer screening in Asian women with dense breasts and those with nondense breasts. Materials and Methods A retrospective database search identified asymptomatic Korean women who underwent digital mammography (DM) and supplemental AB US screening for breast cancer between January 2018 and December 2019. We excluded women without sufficient follow-up, established final diagnosis, or histopathologic results. Performance measures of DM alone and AB US combined with DM (hereafter AB US plus DM) were compared. The primary outcome was cancer detection rate (CDR), and the secondary outcomes were sensitivity and specificity. Subgroup analyses were performed based on mammography density. Results From 2785 screening examinations in 2301 women (mean age, 52 years ± 9 [SD]), 28 cancers were diagnosed (26 screening-detected cancers, two interval cancers). When compared with DM alone, AB US plus DM resulted in a higher CDR of 9.3 per 1000 examinations (95% CI: 7.7, 10.3) versus 6.5 per 1000 examinations (95% CI: 5.2, 7.2; P < .001) and a higher sensitivity of 90.9% (95% CI: 77.3, 100.0) versus 63.6% (95% CI: 40.9, 81.8; P < .001) but a lower specificity of 86.8% (95% CI: 85.2, 88.2) versus 94.6% (95% CI: 93.6, 95.5; P < .001) in women with dense breasts. In women with nondense breasts, AB US plus DM resulted in a higher CDR of 9.5 per 1000 examinations (95% CI: 7.1, 10.6) versus 6.3 per 1000 examinations (95% CI: 3.5, 7.1; P < .001), whereas specificity was lower at 95.2% (95% CI: 93.4, 96.8) versus 97.1% (95% CI: 95.8, 98.4; P < .001). Conclusion In Asian women, the addition of automated breast US to digital mammography showed higher cancer detection rates but lower specificities in both dense and nondense breasts. © RSNA, 2023 Supplemental material is available for this article.

5 September 2022 in Tobacco Induced Diseases
Verified
Journal Article
Open access
SOSupa Oh
Supa Oh
SKSinae Kim
Sinae Kim
ESEunju Sung
Eunju Sung
CKCheol-Hwan Kim
Cheol-Hwan Kim
JKJae-Heon Kang
Jae-Heon Kang
ICIn Young Cho
In Young Cho
Introduction: Cigarette smoking is suggested to be associated with sleep problems. This study evaluated the quantitative association between urinary cotinine-verified smoking intensity and sleep quality assessed by the Pittsburgh Sleep Quality Index (PSQI). Methods: This was a...

1 January 2024 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
JKJi Hyun Kim
Ji Hyun Kim
YLYumi Lee
Yumi Lee
DKDa-Young Kim
Da-Young Kim
SKSinae Kim
Sinae Kim
SSSang Soo Seo
Sang Soo Seo
MLMyong Cheol Lim
Myong Cheol Lim
Kim JH, et al. J Gynecol Oncol. 2023 Sep;35:e3. https://doi.org/10.3802/jgo.2024.35.e3

1 May 2020 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
DGDakim K. Gaines
Dakim K. Gaines
NYNikhil Yegya-Raman
Nikhil Yegya-Raman
SKSinae Kim
Sinae Kim
CSCharles Simone
Charles Simone
CRChristina Theodorou Ross
Christina Theodorou Ross
SJSalma Jabbour
Salma Jabbour
Background: We hypothesized that significant tumor volume reduction (TVR) occurs over the course of stereotactic body radiotherapy (SBRT) for early stage non-small cell lung cancer (NSCLC), and that TVR correlates with clinical outcomes. Methods: We conducted a retrospective review of patients treated with SBRT for early stage NSCLC across two academic centers. For each patient, we contoured the tumor volume (TV) on cone beam computed tomography (CBCT) images obtained before each treatment fraction. We then calculated TVR based on the TV from the first and last days of treatment. We used log-rank tests to quantify differences in overall survival (OS), progression-free survival (PFS) and recurrence based on TVR. Results: Data from 69 patients and a total of 73 treated tumors were analyzed. The median follow-up for survivors was 51.8 months (range, 6.9 to 80.0 months). The median TVR for the cohort was 10.1% (range, −5.7% to 43.5%). There was no significant difference in either OS (median 33.4 vs. 29.1 months, P=0.79) or PFS (median 26.3 vs. 12.3 months, P=0.43) for those with high TVRs (≥10.1%) vs. low TVRs (<10.1%), respectively. There was a trend toward superior 2-year PFS in the high TVR group (52.2% vs. 36.7%, P=0.062), but this effect diminished on longer follow-up (4-year PFS 31.9% vs. 26.7%, P=0.15). No associations were observed between TVR and local, regional or distant recurrence. Conclusions: We were not able to demonstrate that TVR is a reliable predictive imaging marker for stage I/II NSCLC treated with SBRT. Future studies with larger sample sizes are needed to clarify a potential relationship between TVR and early outcomes.